Zymeworks zymeworks.com


Public lists: BIO 2016 (619)

Zymeworks (NYSE: ZYME) (TSX: ZYME) is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of multifunctional biotherapeutics.

Zymeworks (NYSE: ZYME) (TSX: ZYME) is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of multifunctional biotherapeutics.

Company (IPO / Went public)

Phone: 604-678-1388

Fax:

1385 West 8th Avenue
Suite 540
Vancouver, V6H 3V9
British Columbia, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Zymeworks $205.4M Apr 28, 2017
Bolder BioTechnology $3.5M Dec 5, 2008
Dialectica srl $0M Apr 29, 2017
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Zymeworks Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 15 investors

Competitors

Company Status Description Investors
See all 15 competitors